Abstract |
To assess the role of monocyte chemoattractant protein-1 (MCP-1/CCL2) in the development of fatty liver, we have used LDLr(-/-) mice as an animal model of high-fat, high- cholesterol diet-induced liver steatosis. The rapid dietary induction of hepatic mRNA MCP-1 expression was paralleled by a concomitant increase in plasma MCP-1 that was strongly associated with the degree of liver steatosis. Hepatocytes showed an intense immunoreactivity for MCP-1 that was mainly located surrounding the hepatic lipid droplets. The intake of cholesterol also increased the concentration of MCP-1 in liver homogenates. This was accompanied by a differential expression of members of the PPAR family. Additionally, complete MCP-1 deficiency prevents the development of liver steatosis in LDLr(-/-) mice and partial deficiency is accompanied by a certain protective effect. Our data also suggest that MCP-1 may be important in the regulation of hepatic insulin resistance and may represent a link between inflammation and metabolic diseases. We conclude that dietary cholesterol upregulation of hepatic MCP-1 may help to understand the role of circulating MCP-1 in conditions where liver derangements are clinically important and in the association of liver steatosis with the metabolic syndrome.
|
Authors | Anna Rull, Fernando Rodríguez, Gerard Aragonès, Judit Marsillach, Raúl Beltrán, Carlos Alonso-Villaverde, Jordi Camps, Jorge Joven |
Journal | Cytokine
(Cytokine)
Vol. 48
Issue 3
Pg. 273-9
(Dec 2009)
ISSN: 1096-0023 [Electronic] England |
PMID | 19748796
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Chemokine CCL2
- Cholesterol, Dietary
- RNA, Messenger
|
Topics |
- Animals
- Chemokine CCL2
(genetics, metabolism)
- Cholesterol, Dietary
(pharmacology)
- Fatty Liver
(physiopathology)
- Hepatocytes
(pathology)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- RNA, Messenger
(metabolism)
- Up-Regulation
(drug effects)
|